Somatorelin
VARIOUS
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Somatorelin is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including VIPR1.
- Molecular targets: VIPR1 (1 listed in DrugCentral).
- ATC code: V04CD05 (Tests for pituitary function).
- Molecular formula: C215H357N71O67S; molecular weight 5040.71 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Vasoactive intestinal polypeptide receptor 1 | VIPR1 | agonist | Ki 6.20 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V04CD05 | VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tests for pituitary function |
Chemical structure
| Molecular formula | C215H357N71O67S |
|---|---|
| Molecular weight | 5040.71 g/mol |
| CAS number | 83930-13-6 |
| InChIKey | — |
| PubChem CID | 16132353 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Somatorelin work?
Its molecular targets in DrugCentral include VIPR1 (agonist).
What is the chemical formula of Somatorelin?
Somatorelin has the molecular formula C215H357N71O67S and a molecular weight of 5040.71 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4710 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2108862 — compound record and bioactivity
- PubChem CID 16132353 — chemical identifiers
- DrugBank DB12656 — drug record
- FDA UNII 4UR7N9Z9MM — substance identity
- UniProt P32241 (VIPR1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.